Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00261586Phase 4Completed
Phase 4, randomised, single-blind trial of acetaminophen in pain (7 arms), sponsored by Johnson & Johnson. Primary endpoints: Percent arachidonic acid-induced platelet aggregation at Day 9 and Lanza Mucosal Injury Score of the stomach at Day 9. Status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00261586.